Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Merck
McKinsey
Colorcon
Johnson and Johnson

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Aurobindo Pharma Ltd Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AUROBINDO PHARMA LTD, and what generic and branded alternatives to AUROBINDO PHARMA LTD drugs are available?

AUROBINDO PHARMA LTD has two hundred and ninety approved drugs.

There are sixteen tentative approvals on AUROBINDO PHARMA LTD drugs.

Summary for Aurobindo Pharma Ltd

Drugs and US Patents for Aurobindo Pharma Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE metformin hydrochloride; pioglitazone hydrochloride TABLET;ORAL 200823-001 Feb 13, 2013 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE amlodipine besylate; benazepril hydrochloride CAPSULE;ORAL 202239-002 Sep 5, 2012 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd OLANZAPINE olanzapine TABLET;ORAL 202050-001 Apr 23, 2012 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;INJECTION 207183-001 May 13, 2016 AP RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd ROPIVACAINE HYDROCHLORIDE ropivacaine hydrochloride SOLUTION;INJECTION 205612-005 Jul 13, 2016 AP RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd AMOXICILLIN AND CLAVULANATE POTASSIUM amoxicillin; clavulanate potassium TABLET;ORAL 091569-002 Jan 20, 2012 AB RX No No   Start Trial   Start Trial
Aurobindo Pharma Ltd IBANDRONATE SODIUM ibandronate sodium TABLET;ORAL 204502-001 Mar 11, 2016 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for AUROBINDO PHARMA LTD drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
McKinsey
AstraZeneca
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.